Y-mAbs Announces Data to be Presented at 2019 SIOP
(World News Science)

NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the `Company` or `Y-mAbs`) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, is pleased to announce the acceptance of two oral presentations and five poster presentations at the International Society of Pediatric Oncology (SIOP) Annual Congress held October 23 through October 26, 2019 in Lyon, France. The abstracts for oral presentations are publicly available online at https://siop-congress.org/scientific-programme/ The abstracts include the following presentation of omburtamab, one of...